Deoxynucleotidyltransferase, terminal (DNTT) Peptide
DNTT
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits TdT (DNTT)
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-DNTT antibody (Catalog #: ARP52031_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
- Synonymes
- TdT Peptide, TDT Peptide, BB160593 Peptide, Tdt Peptide, dntt-A Peptide, dntt Peptide, DNA nucleotidylexotransferase Peptide, deoxynucleotidyltransferase, terminal Peptide, DNA nucleotidylexotransferase L homeolog Peptide, terminal deoxynucleotidyl transferase Peptide, DNTT Peptide, dntt Peptide, Dntt Peptide, dntt.L Peptide, tdt Peptide
- Sujet
-
DNTT is a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, DNTT is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. This gene is a member of the DNA polymerase type-X family and encodes a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, the encoded protein is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Alternatively spliced transcript variants encoding different isoforms of this gene have been described.
Alias Symbols: TDT
Protein Interaction Partner: DNTTIP1,DNTTIP2,PCNA,PRPF19,XRCC6,ABTB2,CUL3,DNTTIP2,PCNA,PRPF19,UBC,XRCC6
Protein Size: 509 - Poids moléculaire
- 58 kDa
- ID gène
- 1791
- NCBI Accession
- NM_004088, NP_004079
- UniProt
- P04053
-
Vous êtes ici:
